Europlasma Statistics

Total Valuation

Europlasma has a market cap or net worth of EUR 7.68 million. The enterprise value is 18.86 million.

Market Cap	7.68M
Enterprise Value	18.86M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Europlasma has 1.45 billion shares outstanding. The number of shares has increased by 1,340.94% in one year.

Current Share Class	1.45B
Shares Outstanding	1.45B
Shares Change (YoY)	+1,340.94%
Shares Change (QoQ)	-51.93%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.18
PB Ratio	-0.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.23
EV / Sales	0.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.52

Financial Position

The company has a current ratio of 0.77

Current Ratio	0.77
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.10
Interest Coverage	-8.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-30.38%
Return on Invested Capital (ROIC)	-312.97%
Return on Capital Employed (ROCE)	-208.60%
Revenue Per Employee	107,578
Profits Per Employee	-38,420
Employee Count	398
Asset Turnover	0.79
Inventory Turnover	1.57

Taxes

Income Tax	-2.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.63% in the last 52 weeks. The beta is 773.99, so Europlasma's price volatility has been higher than the market average.

Beta (5Y)	773.99
52-Week Price Change	-98.63%
50-Day Moving Average	0.01
200-Day Moving Average	0.03
Relative Strength Index (RSI)	35.20
Average Volume (20 Days)	43,799,051

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Europlasma had revenue of EUR 42.82 million and -15.29 million in losses. Loss per share was -75.41.

Revenue	42.82M
Gross Profit	22.63M
Operating Income	-26.29M
Pretax Income	-18.66M
Net Income	-15.29M
EBITDA	-13.87M
EBIT	-26.29M
Loss Per Share	-75.41

Full Income Statement

Balance Sheet

The company has 1.75 million in cash and 13.67 million in debt, giving a net cash position of -11.92 million or -0.01 per share.

Cash & Cash Equivalents	1.75M
Total Debt	13.67M
Net Cash	-11.92M
Net Cash Per Share	-0.01
Equity (Book Value)	-11.15M
Book Value Per Share	-0.20
Working Capital	-11.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.88 million and capital expenditures -1.52 million, giving a free cash flow of -12.40 million.

Operating Cash Flow	-10.88M
Capital Expenditures	-1.52M
Free Cash Flow	-12.40M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 52.86%, with operating and profit margins of -61.41% and -35.71%.

Gross Margin	52.86%
Operating Margin	-61.41%
Pretax Margin	-43.59%
Profit Margin	-35.71%
EBITDA Margin	-32.39%
EBIT Margin	-61.41%
FCF Margin	n/a

Dividends & Yields

Europlasma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,340.94%
Shareholder Yield	n/a
Earnings Yield	-199.15%
FCF Yield	-161.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0002.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0002

Scores

Europlasma has an Altman Z-Score of -6.03 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.03
Piotroski F-Score	4